Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-08-03

Clinical Trial Update: A Study To Assess The Safety Of PF-06342674 In Adults With Type 1 Diabetes [Phase 1]

View source ↗

Summary

A Phase 1 safety trial of PF-06342674 in adults with type 1 diabetes has completed and results were posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PF-06342674

Snippet

Sponsor: Pfizer | Conditions: Diabetes Mellitus, Type 1 | Phase 1 | Status: COMPLETED | Results posted: 2018-08-03